China — Vitamins, Minerals, Proteins, and Unconventional Dietary Specialties for Humans

← back to leaderboard

China received 91 FDA import refusals in Vitamins, Minerals, Proteins, and Unconventional Dietary Specialties for Humans between 2023-Q4 and 2026-Q3. Volume peaked at 13 in 2026-Q3, with the trend roughly flat year-on-year. The most-cited issues are unapproved, lacks firm, and list ingre. No trade baseline is published for this commodity from China, so no per-$1B rate is shown here.

Of these, 29 were hazard refusals and 62 were paperwork refusals.

Exporting from China? Get an email when shipments from China are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

3 2023-Q4 2023-Q4: 3 6 2024-Q1 2024-Q1: 6 10 2024-Q2 2024-Q2: 10 5 2024-Q3 2024-Q3: 5 9 2024-Q4 2024-Q4: 9 8 2025-Q1 2025-Q1: 8 7 2025-Q2 2025-Q2: 7 8 2025-Q3 2025-Q3: 8 11 2025-Q4 2025-Q4: 11 8 2026-Q1 2026-Q1: 8 3 2026-Q2 2026-Q2: 3 13 2026-Q3 2026-Q3: 13

By commodity, last 156 weeks

Commodity Rejections Per $1B US imports Most-cited hazard
Supplements 69 unapproved
Herbals-Botanicals 22 unapproved

Recent rejections